A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Clinical trial NCT05812027 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05812027
Sponsor: TScan Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Head and Neck Cancer Cervical Cancer Non Small Cell Lung Cancer HPV16 Related Cancers Sarcoma Uveal Melanoma NUT Carcinoma

Start date: 2023-06-26
Primary completion: 2026-01-01
Enrollment: 1150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.